Home›Search›Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Bentham Science Publishers · United Arab Emirates · Est. 2017

ISSN2214-7527

SJR Q4✓ Scopus / SJR

/ 100

High Risk

Score Breakdown

✓ Scopus Q4+5

Total5

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Score

0.133

H-Index

Total Works

Total Citations

2yr Mean Citedness

1.00

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

Frontiers in Clinical Drug Research - CNS and Neurological Disorders focuses on advances in the development of pharmaceutical agents for central nervous system (CNS) and nerve disorders. The scope includes medicinal chemistry, pharmacology, molecular biology, and biochemistry of molecular targets for neurological and CNS disorders, with an emphasis on clinical and therapeutic aspects of novel drugs. Topics covered include neurodegenerative diseases like Alzheimer's and Parkinson's, pediatric CNS tumors, addiction, and the neurobiology of placebo effects.

AI-summarised from recent articles · verify on the publisher page

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Bottom 25%

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published2017

Annual Volume~ 10 articles / year

StatusActive (last: 2024)

Total Publications80

Publisher OrgBentham Science Publishers

OA Since2017

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2214-7527

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2017

2018

2020

2021

2022

2023

2024

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Neurology (clinical)Q4

Pharmaceutical ScienceQ4

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

Pharmacology (medical)Neurology (clinical)Pharmaceutical Science

Research Topics (OpenAlex)

Legal Cases and CommentaryCholinesterase and Neurodegenerative DiseasesDiverse Scientific and Economic StudiesHuman auditory perception and evaluationCancer Treatment and PharmacologyPharmacological Effects and Toxicity StudiesEpilepsy research and treatmentMedicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsAttention Deficit Hyperactivity Disorder